文献速递生殖医学

胚胎来源细胞外囊泡作为IVF胚胎质量生物标志物的系统综述

Embryo-derived extracellular vesicles and their potential as biomarkers for embryo quality during IVF: a systematic review.
PubMed 文献 · Hum Reprod Update · 2026-01-01

综述发现胚胎来源细胞外囊泡的浓度和大小变异大,与胚胎发育能力的关联证据确定性极低,目前证据不支持将其作为IVF中的生物标志物。

要点

  • 胚胎EV浓度和大小变异大,研究设计差异是主要原因。
  • 现有文献质量低至中等,关联证据确定性极低。
  • 目前证据不支持胚胎EV作为IVF胚胎选择生物标志物。

核心结论

  • 当前证据不支持在IVF过程中使用胚胎来源细胞外囊泡作为生物标志物。

研究设计与样本

  • 遵循PRISMA指南的系统综述,检索MEDLINE、EMBASE、BIOSIS Previews、Web of Science和Scopus五个数据库,检索日期为2026年1月14日。
  • 纳入标准为收集任何哺乳动物物种的胚胎培养基并分离和评估其中的细胞外囊泡。

主要发现

  • 胚胎EV浓度和大小报告存在广泛变异,主要因研究设计差异所致。
  • 现有文献质量整体为低至中等质量。
  • 在3项人类和8项牛研究中,评估胚胎EV浓度、大小和/或货物与发育能力关联的所有结局证据确定性均为极低。
  • 研究常报告相反方向的效应,其他研究则显示无明确关联。

临床怎么用

  • 当前证据不支持将胚胎EV作为IVF中的生物标志物用于胚胎选择。
  • 未来研究应采用标准化的EV分离和表征方法,并遵循最佳实践。
  • 应标准化EV采样时间,使用适当的培养基对照,并报告最佳发育能力指标如活产。

局限性

  • EV分离技术、EV采样时间和胚胎质量评估方法的不一致性妨碍了评估胚胎EV能否作为可靠生物标志物。
  • 现有文献质量低至中等,证据确定性极低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Over the past decade, extracellular vesicles (EVs) released from embryos have received increasing attention for their potential role in influencing embryo-maternal communication events during implantation. Several studies have explored the relationship between embryo-derived EVs and embryo developmental competence. To synthesize current insights, we conducted a systematic review of the literature, highlighting key findings and evaluating how embryo EV profiles relate to embryo developmental competence. OBJECTIVE AND RATIONALE: A systematic review was conducted in accordance with the PRISMA guidelines. The review intended to (i) synthesize the existing knowledge on embryo-derived EV concentration, size, and cargo and their association with embryo developmental competence in mammalian systems, (ii) propose recommendations for future research, and (iii) assess the potential impact of the current literature on embryo selection during IVF. SEARCH METHODS: A literature search was performed across five databases (MEDLINE, EMBASE, BIOSIS Previews, Web of Science, and Scopus), involving keywords 'Embryo' AND 'Extracellular vesicle'; many synonyms were included for each keyword along with map terms when available. The search was conducted on 14 January 2026. References were screened for additional relevant records. Abstract-only authors were contacted to determine whether full-text was available. The inclusion criteria were 'collection of culture media from embryos of any mammalian species and isolation and assessment of EVs from it'. Reasons for exclusion included: 'No collection of embryo culture media', 'No characterisation or assessment of EVs', 'Not embryo-derived EVs', and 'Review/Theory/Lacking primary data'. OUTCOMES: Our searches collected a total of 15 620 records; of these, 32 studies from 34 records were included in the systematic review. The included studies were divided into two groups: (i) studies of embryonic EV characteristics and (ii) studies that investigated the association of embryonic EV characteristics and embryo developmental competence, including embryo quality assessments based on morphology, ploidy, and pregnancy. Wide variations in embryo EV concentration and size were reported, largely due to differences in study designs. Overall, the quality of the existing literature ranged from low to moderate quality. Among the three human and eight bovine studies that examined the association of embryo EV concentration, size, and/or cargo with developmental competence, the certainty of the evidence for all outcomes was consistently very low. Studies often reported opposing directions of effects, whilst others showed no clear association. Inconsistencies in EV isolation techniques, timing of EV sampling, and methods for embryo quality assessments complicate efforts to assess whether embryonic EVs can be used as a reliable biomarker. WIDER IMPLICATIONS: Current evidence does not support the use of embryo EVs as biomarkers during IVF procedures. To enhance reproducibility and the production of high-quality studies, it is recommended that studies incorporate standardized approaches to EV isolation and characterization to align with best practices. In addition, the timing of EV sampling should be standardized, appropriate media controls used, and optimal measures of developmental competence, such as live birth, reported. Adherence to these recommendations will enable future studies to build constructively on the existing literature, with the possibility of informing clinical applications that improve patient outcomes. REGISTRATION NUMBER: https://doi.org/10.17605/OSF.IO/TPXVU.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. Boom G, Jordan V, Chamley LW, et al. Embryo-derived extracellular vesicles and their potential as biomarkers for embryo quality during IVF: a systematic review. Hum Reprod Update. 2026. PMID: 42168775. doi:10.1093/humupd/dmag014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。